Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 12/2007

01-12-2007 | Case Report

Osseous mastocytosis of the knee

Authors: T. Harzy, A. El Hajjaji

Published in: Clinical Rheumatology | Issue 12/2007

Login to get access

Abstract

Mastocytosis is a rare pathology with possible bone involvement. This report describes an unusual case of solitary osteolytic lesion of the proximal right tibia, revealing an osseous mastocytosis, treated by bone cement injection. Follow-up showed a good clinical and radiological outcome, and the patient remains symptom-free 9 months after her surgery. To our knowledge, this is the first case reported in the literature.
Literature
1.
Travis WD, Li CY, Bergstrahl EJ, Yam LT, Swee RG (1988) Systemic mast cell disease: analysis of 58 cases and literature review. Medicine 67:345–368CrossRefPubMed
2.
Sagher F, Cohen C, Schorr S (1952) Concomitant bone changes in urticaria pigmentosa. J Invest Dermatol 18:425–32CrossRefPubMed
3.
Barer M, Peterson LFA, Dahlin DC, Winkelmann RK, Stewart JR (1968) Mastocytosis with osseous lesions resembling metastatic malignant lesions in bone. J Bone Jt Surg 50 A:142–152CrossRef
4.
Delsignore JL, Dvoretsky PM, Hicks DG, O’Keefe RJ, Rosier RN (1996) Mastocytosis presenting as a skeletal disorder. Iowa Orthop J 16:126–134PubMedPubMedCentral
5.
Macro M, Reman O, Courtheoux F, Troussard X, Tillet I, Galateau F et al (1990) Systemic mastocytosis. Polymorphism of bone involvement. Report of 3 cases 2 of which with diffuse osteocondensation. Rev Rhum Mal Osteoartic 57:653–660PubMed
6.
Chines A, Pacifici R, Avioli LV, Teitelbaum SL, Korenblat PE (1991) Systemic mastocytosis presenting as osteoporosis: a clinical and histomorphometric study. J Clin Endocrinol Metab 72:140–144CrossRefPubMed
7.
Deramond H, Remond A, Grumbach Y, Dieval M, Coevoet B, Duriez J, Katz M (1980) Bone locations of systemic mastocytosis: radiological and scintigraphic study (author’s transl). J Radiol 61:503–508PubMed
8.
Rodenberg JC, Maegaard KK, Svanholm H (1986) Case report 369: systemic mastocytosis. Skeletal Radiol 15:334–337CrossRefPubMed
9.
Lortholary O, Casassus P, Laroche L, Lortholary P, Diebold J (1990) Systemic mastocytosis and malignant mastocytosis. Presse Med 19:125–128PubMed
Metadata
Title
Osseous mastocytosis of the knee
Authors
T. Harzy
A. El Hajjaji
Publication date
01-12-2007
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 12/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0651-9

Other articles of this Issue 12/2007

Clinical Rheumatology 12/2007 Go to the issue

Original Article

Accrual of organ damage over time in Argentine patients with systemic lupus erythematosus: a multi-centre study

Case Report

The role of PET/CT in Cogan’s syndrome

Original Article

Performance of the osteoporosis risk assessment tool in Moroccan men

Original Article

Prognosis of clinical renal disease and incidence of new renal findings in patients with rheumatoid arthritis: follow-up of a population-based study

Case Report

Efficacy of intravenous immunoglobulin treatment in lupus erythematosus chorea

Case Report

Marked improvement of Churg–Strauss vasculitis with intravenous gamma globulins during pregnancy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits